Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
|
|
Elevance Health, Inc. (ANTM)
|
|
| Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Government Business | 82,919.0 | 71,572.0 | 62,632.0 | 55,348.0 | 48,145.0 | 45,283.0 | 40,307.1 | 33,344.6 |
| Commercial and Specialty Business | 38,809.0 | 36,699.0 | 37,421.0 | 35,782.0 | 35,503.0 | 33,577.0 | 33,078.0 | |
| Other | | | | | | | 21.0 | 25.7 |
| Other | 16,911.0 | 13,596.0 | 4,160.0 | 975.0 | 6,392.0 | 6,003.0 | 5,750.4 | 40,503.8 |
| Total revenues | 138,639.0 | 121,867.0 | 104,213.0 | 92,105.0 | 90,040.0 | 84,863.0 | 79,156.5 | 73,874.1 |
| Revenue growth | 13.8% | 16.9% | 13.1% | 2.3% | 6.1% | 7.2% | 7.2% | 4.0% |
| Loss and loss adjustment expenses | 102,645.0 | 88,045.0 | 81,786.0 | 71,895.0 | 72,236.0 | 66,834.0 | 61,116.9 | 56,854.9 |
| Investment expenses | 41.0 | 38.0 | 29.0 | 41.0 | 41.0 | 44.0 | 41.2 | |
| Other operating expenses | 27,230.0 | 26,762.0 | 15,667.0 | 14,348.0 | 13,060.0 | 12,707.0 | 12,714.4 | 12,050.4 |
| General and administrative | | | | | | | 11,093.7 | 10,258.3 |
| EBITDA | 17,119.0 | 15,108.0 | 14,070.0 | 12,862.0 | 5,312.0 | 6,190.0 | 6,201.2 | 5,900.9 |
| EBITDA margin | 12.3% | 12.4% | 13.5% | 14.0% | 5.9% | 7.3% | 7.8% | 8.0% |
| Depreciation | 861.0 | 793.0 | 795.0 | 774.0 | 111.0 | 104.0 | 105.8 | 106.5 |
| EBITA | 16,258.0 | 14,315.0 | 13,275.0 | 12,088.0 | 5,201.0 | 6,086.0 | 6,095.4 | 5,794.4 |
| EBITA margin | 11.7% | 11.7% | 12.7% | 13.1% | 5.8% | 7.2% | 7.7% | 7.8% |
| Amortization of intangibles | 441.0 | 361.0 | 338.0 | 358.0 | 780.0 | 808.0 | 802.1 | 744.5 |
| EBIT | 15,817.0 | 13,954.0 | 12,937.0 | 11,730.0 | 4,421.0 | 5,278.0 | 5,293.3 | 5,049.9 |
| EBIT margin | 11.4% | 11.5% | 12.4% | 12.7% | 4.9% | 6.2% | 6.7% | 6.8% |
| Interest expense, net [+] | 819.0 | 820.0 | 748.0 | 764.0 | 1,021.0 | 723.0 | 643.7 | 681.8 |
| Interest expense | 798.0 | 784.0 | 746.0 | 753.0 | 739.0 | 723.0 | 653.0 | 600.7 |
| Interest income | -21.0 | -36.0 | -2.0 | -11.0 | -282.0 | | 9.3 | -81.1 |
| Other income (expense), net | -6,913.0 | -6,315.0 | -6,208.0 | -5,920.0 | | | | |
| Pre-tax income | 7,925.0 | 6,238.0 | 5,985.0 | 5,068.0 | 3,964.0 | 4,555.0 | 4,631.0 | 4,368.1 |
| Income taxes | 1,830.0 | 1,666.0 | 1,178.0 | 1,318.0 | 121.0 | 2,085.0 | 2,071.0 | 1,808.0 |
| Tax rate | 23.1% | 26.7% | 19.7% | 26.0% | 3.1% | 45.8% | 44.7% | 41.4% |
| Minority interest | -9.0 | | | | | | | |
| Earnings from continuing ops | 6,104.0 | 4,572.0 | 4,807.0 | 3,750.0 | 3,843.0 | 2,470.0 | 2,560.0 | 2,560.1 |
| Earnings from discontinued ops | | | | | | | | 9.6 |
| Net income | 6,104.0 | 4,572.0 | 4,807.0 | 3,750.0 | 3,843.0 | 2,470.0 | 2,560.0 | 2,569.7 |
| Net margin | 4.4% | 3.8% | 4.6% | 4.1% | 4.3% | 2.9% | 3.2% | 3.5% |
| |
| Basic EPS | $25.04 | $18.23 | $18.81 | $14.53 | $14.70 | $9.40 | $9.73 | $9.28 |
| Diluted EPS | $24.73 | $17.98 | $18.47 | $14.19 | $14.35 | $9.21 | $9.38 | $8.95 |
| |
| Shares outstanding (basic) | 243.8 | 250.8 | 255.5 | 258.1 | 261.5 | 262.9 | 263.0 | 275.9 |
| Shares outstanding (diluted) | 246.8 | 254.3 | 260.3 | 264.2 | 267.8 | 268.1 | 272.9 | 285.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|